Licensees & Portfolio Companies
Licensees & Portfolio Companies
Clayton Biotechnologies, Inc. works with biomedical companies to commercialize discoveries and innovations that arise in the research projects at the Clayton Foundation and its supporting entities. Such technologies have been previously licensed to or are currently being developed by the companies listed below. We also license research tools to companies to help the development and creation of innovative products.
- Abbott
- Aravasc, Inc.
- Athena Diagnostics
- BioCad
- Focus Diagnostics
- AbBC Therapies
- Janssen
- Merck & Co., Inc.
- Neurocrine Biosciences
- Quest Diagnostics
- SkyePharma
- Viacyte
- Antech Diagnostics
- argenx
- Avicin Therapeutics
- bluebird bio
- Genzyme
- Idexx Laboratories
- Lilly
- Molmed
- Oxford Biomedica
- Renova Therapeutics
- Supergen
Clayton Biotechnologies, Inc. works with biomedical companies to commercialize Clayton Foundation discoveries and innovations. Clayton Foundation technologies have been licensed to or are currently being developed by the companies listed below. We also license research tools to companies to help the development and creation of novel innovative products.
- Abologix, Sàrl
- Clarity Medical Systems
- Depotech, Inc.
- Neurix SA
- Pacira Pharmaceuticals
- Positron Corporation
- Spectracell Laboratories
- Vacunax
- Veana LLC